Retatrutide for Men Over 50

The 50s are a critical decade for men's health. Cardiovascular disease risk escalates sharply -- heart attacks in men peak between ages 55-65. Testosterone declines approximately 1-2% per year after age 30, and obesity accelerates this decline dramatically. Visceral fat -- the belly fat that accumulates preferentially in men -- is at its most metabolically dangerous during this period, driving insulin resistance, hypertension, and dyslipidemia. For men who have carried excess weight into their 50s, the accumulated metabolic damage demands urgent attention. Retatrutide's ability to produce 24% weight loss while targeting visceral fat through glucagon activation makes it a potentially transformative treatment for this demographic.

Cardiovascular Urgency After 50

For men over 50, cardiovascular risk is the most pressing health concern. Decades of visceral fat accumulation have likely caused arterial plaque buildup, arterial stiffness, and left ventricular hypertrophy. Every additional year of obesity accelerates this damage. The cardiovascular benefits of significant weight loss -- blood pressure reduction, lipid improvement, reduced inflammation, and improved endothelial function -- are most urgently needed in this age group. Semaglutide has already proven cardiovascular risk reduction in the SELECT trial.

Testosterone and Weight Loss

Obesity-related testosterone decline compounds the natural age-related decline, often pushing men into clinically low ranges that cause fatigue, muscle loss, low libido, depression, and cognitive fog. Weight loss of 15-25% can increase testosterone by 50-100+ ng/dL. For some men, this is the difference between needing testosterone replacement therapy and recovering sufficient natural production. The additional muscle-preserving effects of improved testosterone create a positive feedback loop that supports long-term weight maintenance.

Fighting Sarcopenia During Weight Loss

Men over 50 lose 1-2% of muscle mass per year even without weight loss. Adding pharmaceutical weight loss to this baseline creates a risk of significant functional decline if not properly managed. Essential strategies include protein intake of 1.2-1.6 g/kg/day, prioritizing leucine-rich sources, resistance training at least 3 times weekly with progressive overload, and adequate sleep for muscle recovery and testosterone production.

Pre-Treatment Health Screening

Men over 50 should undergo comprehensive screening before starting weight loss medication. This includes complete cardiovascular assessment (lipids, blood pressure, cardiac risk calculator, potentially stress test for high-risk individuals), metabolic panel (fasting glucose, HbA1c, kidney and liver function), hormonal assessment (total and free testosterone, thyroid function), cancer screening (age-appropriate -- PSA, colonoscopy), and sleep apnea screening (extremely common in obese men over 50).

Your Health Cannot Wait

Compounded semaglutide ($99/mo) and compounded tirzepatide ($125/mo) are available today. Every year of improved metabolic health reduces your cumulative cardiovascular risk and improves quality of life.